Not applicableApproved For MarketingNCT02592941
What this trial is testing
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy
Who this might be right for
Duchenne Muscular Dystrophy
PTC Therapeutics